
    
      The use of beta blockers is an important component of drug therapy for myocardial infarction,
      but in some exceptional cases, evidence-based evidence for their use is insufficient, and we
      seek to understand the prognostic impact of beta blockers on patients enrolled in long-term
      follow-up.
    
  